Financials Future Health ESG Corp.

Equities

FHLT

US36118W1027

Investment Holding Companies

Delayed Nasdaq 04:30:00 2024-05-01 pm EDT 5-day change 1st Jan Change
12 USD -2.20% Intraday chart for Future Health ESG Corp. -2.44% +12.46%

Valuation

Fiscal Period: December 2021 2022 2023
Capitalization 1 243.8 252.5 70.33
Enterprise Value (EV) 1 242.3 251.7 70.21
P/E ratio - 4,086 x -1,452 x
Yield - - -
Capitalization / Revenue - - -
EV / Revenue - - -
EV / EBITDA - - -
EV / FCF - -854,581,569 x 10,350,694 x
FCF Yield - -0% 0%
Price to Book -32.5 x -7.09 x -6.16 x
Nbr of stocks (in thousands) 25,000 25,000 6,592
Reference price 2 9.750 10.10 10.67
Announcement Date 3/28/22 3/9/23 3/20/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.2248 -2.407 -0.6786
Operating Margin - - -
Earnings before Tax (EBT) 1 -0.2171 0.2046 0.1056
Net income 1 -0.2171 0.0598 -0.0484
Net margin - - -
EPS - 0.002472 -0.007350
Free Cash Flow - -0.2945 6.783
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 3/28/22 3/9/23 3/20/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 1.45 0.84 0.12
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.29 6.78
ROE (net income / shareholders' equity) - -0.71% 0.49%
ROA (Net income/ Total Assets) - -1.37% -2.46%
Assets 1 - -4.37 1.969
Book Value Per Share 2 -0.3000 -1.420 -1.730
Cash Flow per Share 2 0.0600 0.1300 0.0200
Capex - - -
Capex / Sales - - -
Announcement Date 3/28/22 3/9/23 3/20/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. FHLT Stock
  4. Financials Future Health ESG Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW